Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:40 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 127 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Heart Transplant Surgery Clear all

Conditions: Coronary Artery Bypass Graft Surgery, Myocardial Ischemia, Reperfusion Injury
Interventions: (MC-1) Pyridoxal 5'-phosphate; Drug
Lead sponsor: Medicure; Industry
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Coronary Artery Disease, Heart Diseases
Interventions: Single arterial graft, Multiple arterial grafting; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 4,300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2030
U.S. locations: 11
States / cities: Boulder, Colorado • Springfield, Massachusetts • Lincoln, Nebraska + 5 more

Conditions: Bloodloss, Surgical Procedures, Operative
Interventions: ecallantide, placebo; Drug
Lead sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA); Industry
Eligibility: 18 Years to 85 Years
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 21
States / cities: Birmingham, Alabama • Montgomery, Alabama • Aurora, Colorado + 14 more

Conditions: Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s)
Interventions: eSVS Mesh treated saphenous vein graft, Control saphenous vein graft; Device · Other
Lead sponsor: Kips Bay Medical, Inc.; Industry
Eligibility: 21 Years to 85 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 5
States / cities: Atlanta, Georgia • Gainesville, Georgia • Rochester, Minnesota + 2 more

Conditions: Heart Transplant Surgery, Lung Transplant Surgery
Interventions: iNO, iEPO; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 519 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Coronary Artery Bypass Grafting
Interventions: BoneSeal, Ostene; Device
Lead sponsor: Loma Linda University; Other
Eligibility: 45 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Coronary Artery Disease, Coronary Artery Bypass Graft Surgery
Interventions: neuromuscular electrical stimulation; Device
Lead sponsor: University of Vermont; Other
Eligibility: 50 Years to 80 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Procalcitonin, Coronary Artery Bypass Grafting
Interventions: Not listed
Lead sponsor: Tampa Bay Heart Foundation; Other
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 1
States / cities: Clearwater, Florida

Conditions: Thrombocytopenia, Thrombosis, Cardiac Disease, Coronary Artery Bypass Surgery
Interventions: Angiomax (bivalirudin) anticoagulant; Drug
Lead sponsor: The Medicines Company; Industry
Eligibility: 18 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Coronary Artery Bypass Graft Surgery
Interventions: Regulating Mean Arterial Pressure during cardiopulmonary bypass; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1991 – 1994
U.S. locations: 1
States / cities: New York, New York

Conditions: Surgery, Pneumonia, Surgical Site Infection
Interventions: Continuous Sternal Block, Opioid based analgesia; Device · Drug
Lead sponsor: Halyard Health; Industry
Eligibility: 18 Years and older
Enrollment: 647 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 8
States / cities: Birmingham, Alabama • Newark, Delaware • Lexington, Kentucky + 5 more

Conditions: Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Graft Surgery (CABG), Chronic Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Valve Repair or Replacement, Stable Angina Pectoris
Interventions: CBCR, BRIDGE mHealth intervention; Other · Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Coronary Artery Disease
Interventions: Coronary Artery Bypass; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Atrial Fibrillation
Interventions: sphygmomanometer cuff inflations, standard of care; Other
Lead sponsor: Baystate Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 410 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Springfield, Massachusetts

Conditions: Blood Recovery
Interventions: Hand Wrung, ProCell Wrung; Procedure · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cardiovascular Disease
Interventions: Hemolink (hemoglobin raffimer IV solution); Drug
Lead sponsor: Hemosol; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 19
States / cities: San Francisco, California • Stanford, California • Sarasota, Florida + 14 more

Conditions: Coronary Artery Disease, Heart Valve Disease
Interventions: NO-NUMO™ High Vacuum Body Cavity Drainage System, PVC Chest Tube; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Orange, California

Conditions: Delirium, Congenital Heart Disease, Coronary Artery Disease, Heart Valve Disease
Interventions: Remote ischemic pre-conditioning, Delirium Assessment; Procedure · Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Anemia
Interventions: Blood transfusion at hematocrit value less than 24%, Blood transfusion at hematocrit value less than 28%; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 722 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Pain
Interventions: Parecoxib Sodium/Valdecoxib, Placebo/Valdecoxib, Placebo/Placebo; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 1,671 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 84
States / cities: Fairhope, Alabama • Mobile, Alabama • Tucson, Arizona + 61 more

Conditions: Coronary Disease
Interventions: INS50589 Intravenous Infusion; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 160 participants
Timeline: Started 2006
U.S. locations: 27
States / cities: Birmingham, Alabama • San Diego, California • Springfield, Illinois + 13 more

Conditions: Blood Recovery
Interventions: Hand Wrung, ProCell Wrung; Procedure · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cardiac Surgery, Coronary Artery Bypass Grafting, Valve Surgery, Kidney Injury
Interventions: AP214, Placebo; Drug
Lead sponsor: Action Pharma A/S; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Tufts Medical Center; Other
Eligibility: 20 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG

Randomization of Single vs Multiple Arterial Grafts

A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume

The eMESH 1 Feasibility Study

Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes

Effectiveness of BoneSeal® on Bone Hemostats in Patients Undergoing Cardiothoracic Surgery

Transitional Rehabilitation in CABG Patients

Prospective Review of Procalcitonin After Cardiac Surgery

Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)

Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)

Multicenter Infection Surveillance Study Following Open Heart Surgery

BRIDGE Trial: Embedding Consumer-grade mHealth Technologies Into Cardiac Rehabilitation

SMART Trial Longitudinal Follow-Up:Off-Pump Versus On-Pump Coronary Artery Bypass Surgery

Effect of Remote Ischemic Preconditioning on Incidence of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Graft Surgery

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell): Delayed Impact

Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery

A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery

An Intervention to Reduce Delirium After Cardiac Surgery

Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery

A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery

Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)

Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery

Using WHOOP Fitness Band to Measure Heart Health Variability Before and After Surgery